Elevated plasma p-tau231 is associated with reduced generalization and medial temporal lobe dynamic network

Miray Budak1, Bernadette A Fausto2, Zuzanna Osiecka2

  • 1Center for Molecular & Behavioral Neuroscience, Rutgers University-Newark, 197 University Avenue, Suite 209, Newark, NJ, 07102, USA. miray.budak@rutgers.edu.

PubMed
Abstract

Insights

Higher plasma phosphorylated tau (p-tau) levels, specifically p-tau231, are linked to impaired generalization abilities and reduced medial temporal lobe (MTL) network flexibility in older African Americans, suggesting p-tau231 as a potential biomarker for cognitive decline.

Area of Science:

  • Neuroscience
  • Biomarkers
  • Cognitive Aging

Background:

  • Plasma phosphorylated tau (p-tau) and amyloid beta (Aβ) offer minimally invasive Alzheimer's disease (AD) assessment.
  • Medial temporal lobe (MTL) integrity changes indicate AD progression.
  • MTL dynamic network flexibility predicts cognitive decline and neural changes in preclinical AD.

Purpose of the Study:

  • Investigate relationships between long-term memory, generalization, and MTL dynamic network flexibility.
  • Determine how plasma p-tau231, p-tau181, and Aβ42/Aβ40 influence generalization, memory, and MTL dynamics.
  • Examine these factors in cognitively unimpaired older African Americans.

Main Methods:

  • 148 cognitively unimpaired older African Americans participated.
  • Generalization assessed via Rutgers Acquired Equivalence Task; long-term memory via RAVLT delayed recall.
  • MTL dynamic network connectivity measured using fMRI; plasma biomarkers (p-tau231, p-tau181, Aβ42/Aβ40) quantified.

Main Results:

  • Generalization performance positively correlated with MTL Dynamic Network Flexibility.
  • Generalization performance negatively correlated with plasma p-tau231 and p-tau181.
  • Plasma p-tau231 negatively correlated with MTL Dynamic Network Flexibility.

Conclusions:

  • Elevated plasma p-tau231 associated with impaired generalization and reduced MTL dynamic network flexibility.
  • Plasma p-tau231 may indicate cognitive decline and neural changes in unimpaired older African Americans.
  • These findings highlight p-tau231 as a potential blood-based biomarker for early AD-related changes.